Clinical Trial Update: Effects of Lactobacillus Delbruckii Lactis DN111244 Fermented Milk Consumption on Plasma Lipids Levels in Hypercholesterolaemic Adults [NA]

View source ↗

Summary

This completed clinical trial studied whether daily consumption of Lactobacillus Delbruckii Lactis DN111244 fermented milk affects plasma lipid levels in adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: Danone Global Research & Innovation Center | Conditions: Hypercholesterolemia | NA | Status: COMPLETED